KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $2.1 billion.

  • Medtronic's Accumulated Expenses rose 1251.98% to $2.1 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $2.1 billion, marking a year-over-year increase of 1251.98%. This contributed to the annual value of $2.5 billion for FY2025, which is 585.26% up from last year.
  • Latest data reveals that Medtronic reported Accumulated Expenses of $2.1 billion as of Q4 2025, which was up 1251.98% from $2.0 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Accumulated Expenses registered a high of $2.5 billion during Q2 2025, and its lowest value of $1.7 billion during Q3 2023.
  • For the 5-year period, Medtronic's Accumulated Expenses averaged around $2.1 billion, with its median value being $2.0 billion (2023).
  • Per our database at Business Quant, Medtronic's Accumulated Expenses skyrocketed by 3069.67% in 2021 and then tumbled by 1454.47% in 2022.
  • Medtronic's Accumulated Expenses (Quarter) stood at $1.9 billion in 2021, then dropped by 11.01% to $1.7 billion in 2022, then rose by 2.15% to $1.8 billion in 2023, then rose by 7.68% to $1.9 billion in 2024, then grew by 12.52% to $2.1 billion in 2025.
  • Its Accumulated Expenses stands at $2.1 billion for Q4 2025, versus $2.0 billion for Q3 2025 and $2.5 billion for Q2 2025.